Fifteen such markers have previously been identified for pediatric acute lymphoblastic leukemia (ALL).
目前已发现有十五种这样的生物标志物用于辨别小儿急性淋巴细胞白血病(all)。
Clofarabine injection is indicated for the treatment of pediatric patients (ages 1-21 years) with relapsed or refractory acute lymphoblastic leukemia after at least 2 previous regimens.
氯法拉滨注射液适用于对至少2种治疗方案无效的儿童(1 - 21岁)难治性或复发性急性淋巴细胞白血病的治疗。
应用推荐